Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company manufactures pharmaceutical products. It offers sterile formulations such as liquid and dry parenterlas and non-sterile formulations.
Elysium Pharmaceuticals Ltd, is an unlisted public company incorporated on 11 January, 1995. It is classified as a public limited company and is located in , Gujarat. It's authorized share capital is INR 22.00 cr and the total paid-up capital is INR 16.00 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Yashwantrai Chunibhai Patel
Shareholder
|
00011865 | 10 years |
| Director | Vithalbhai Shankerbhai Patel | 00412203 | 19 years |
| Director | Chandani Jhanwar | 08895542 | 3 years |
| Whole-time Director | Suhasini Rajnikant Patel
Shareholder
|
00013506 | 14 years |
| Whole-time Director | Jinkal Darshan Patel
Shareholder
|
08729869 | 6 years |
| Whole-time Director | Shitalkumar Navnitbhai Patel
Shareholder
|
02468307 | 6 years |
| Additional Director | Hiren Prakash Barot | 02468692 | 1 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 2
Total Amount : 62.6 cr
Bank of Baroda
No. of Loans: 1
Total Amount : 18.4 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| KANAIYA CONSTRUCTION PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ATLANTA ELECTRICALS LIMITED |
Active
|
14.3 Cr | 1 | Gujarat |
| RATNADEEP METAL AND TUBES LIMITED |
Active
|
30.5 Cr | 1 | Gujarat |
Read more
The incorporation date of ELYSIUM PHARMACEUTICALS LTD is 11 January, 1995
The authorized share capital of ELYSIUM PHARMACEUTICALS LTD is INR ₹ 22.0 Cr.
The paid-up capital of ELYSIUM PHARMACEUTICALS LTD is INR ₹ 16.0 Cr.
The registered address of ELYSIUM PHARMACEUTICALS LTD is PLOT NO.1175, P.O. DABHASA, TAL. PADRA, VADODARA, Gujarat, India, 391440 - 391440
The CIN number of ELYSIUM PHARMACEUTICALS LTD is U24231GJ1995PLC024164.